This company listing is no longer active
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Alzinova Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Alzinova's earnings have been declining at an average annual rate of -27%, while the Biotechs industry saw earnings growing at 11.8% annually. Revenues have been growing at an average rate of 16.6% per year.
Belangrijke informatie
-27.0%
Groei van de winst
10.6%
Groei van de winst per aandeel
| Biotechs Groei van de industrie | 0.7% |
| Inkomstengroei | 16.6% |
| Rendement op eigen vermogen | -15.8% |
| Nettomarge | -95.1% |
| Volgende winstupdate | 22 Aug 2024 |
Recente prestatie-updates uit het verleden
Geen updates
Recent updates
Opbrengsten en kosten
Hoe Alzinova geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 31 Mar 24 | 18 | -17 | 35 | 0 |
| 31 Dec 23 | 20 | -16 | 36 | 0 |
| 30 Sep 23 | 17 | -16 | 34 | 0 |
| 30 Jun 23 | 17 | -16 | 33 | 0 |
| 31 Mar 23 | 14 | -15 | 29 | 0 |
| 31 Dec 22 | 17 | -13 | 30 | 0 |
| 30 Sep 22 | 16 | -11 | 27 | 0 |
| 30 Jun 22 | 15 | -9 | 25 | 0 |
| 31 Mar 22 | 17 | -8 | 26 | 0 |
| 31 Dec 21 | 17 | -8 | 25 | 0 |
| 30 Sep 21 | 18 | -7 | 26 | 0 |
| 30 Jun 21 | 19 | -7 | 26 | 0 |
| 31 Mar 21 | 16 | -6 | 22 | 0 |
| 31 Dec 20 | 15 | -6 | 21 | 0 |
| 30 Sep 20 | 13 | -7 | 20 | 0 |
| 30 Jun 20 | 12 | -6 | 18 | 0 |
| 31 Mar 20 | 11 | -7 | 18 | 0 |
| 31 Dec 19 | 7 | -6 | 13 | 0 |
| 30 Sep 19 | 5 | -5 | 10 | 0 |
| 30 Jun 19 | 6 | -5 | 12 | 0 |
| 31 Mar 19 | 8 | -5 | 13 | 0 |
| 31 Dec 18 | 9 | -4 | 14 | 0 |
| 30 Sep 18 | 11 | -3 | 14 | 0 |
| 30 Jun 18 | 10 | -3 | 13 | 0 |
| 31 Mar 18 | 8 | -2 | 11 | 0 |
| 31 Dec 17 | 6 | -3 | 8 | 0 |
| 30 Sep 17 | 5 | -3 | 8 | 0 |
| 30 Jun 17 | 4 | -3 | 8 | 0 |
| 31 Mar 17 | 5 | -4 | 8 | 0 |
| 31 Dec 16 | 5 | -3 | 8 | 0 |
| 30 Sep 16 | 5 | -4 | 8 | 0 |
| 30 Jun 16 | 4 | -4 | 7 | 0 |
| 31 Mar 16 | 2 | -3 | 6 | 0 |
| 31 Dec 15 | 1 | -3 | 4 | 0 |
| 31 Dec 14 | 1 | 0 | 1 | 0 |
| 31 Dec 13 | 1 | 0 | 1 | 0 |
Kwaliteitswinsten: ALZ BTA is currently unprofitable.
Groeiende winstmarge: ALZ BTA is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: ALZ BTA is unprofitable, and losses have increased over the past 5 years at a rate of 27% per year.
Versnelling van de groei: Unable to compare ALZ BTA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: ALZ BTA is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (2.9%).
Rendement op eigen vermogen
Hoge ROE: ALZ BTA has a negative Return on Equity (-15.77%), as it is currently unprofitable.